A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007).

Publication Type:

Journal Article

Source:

PloS one, Volume 8, Issue 4, p.e60147 (2013)

Keywords:

2013, 259, May 2013

Abstract:

Rectal microbicides are needed to reduce the risk of HIV acquisition associated with unprotected receptive anal intercourse. The MTN-007 study was designed to assess the safety (general and mucosal), adherence, and acceptability of a new reduced glycerin formulation of tenofovir 1% gel.